Next |
home / stock / indp / indp message board
Subject | By | Source | When |
---|---|---|---|
$INDP MomentumIts gaining | Surfacetite | investorshub | 05/08/2023 8:37:38 AM |
$INDP got some short data | DeadCellShadix | investorshub | 05/08/2023 1:32:26 AM |
Price gaining | Surfacetite | investorshub | 05/07/2023 3:23:16 PM |
$INDP MomentumIts now last trade up | MonstaGains | investorshub | 05/03/2023 4:25:58 PM |
The gaining up | MonstaGains | investorshub | 05/01/2023 7:51:29 PM |
Good read | wickerman | investorshub | 04/30/2023 8:11:52 AM |
$INDP what does this mean? | MonstaGains | investorshub | 04/28/2023 12:31:52 PM |
short squeeze signal | MonstaGains | investorshub | 04/27/2023 6:10:32 AM |
The trading | DeadCellShadix | investorshub | 04/25/2023 1:24:40 PM |
$INDP Price gaining | TheFinalCD | investorshub | 04/23/2023 10:48:56 PM |
$INDP and the shorts continue | cityimport | investorshub | 04/23/2023 2:57:16 AM |
Good read | madras50 | investorshub | 04/22/2023 2:54:02 AM |
Time for a bounce? | madras50 | investorshub | 04/22/2023 2:02:56 AM |
MomentumIts now | TheFinalCD | investorshub | 04/21/2023 2:32:27 PM |
$INDP MomentumIts trading | madras50 | investorshub | 04/21/2023 3:03:40 AM |
Price gaining last trade up | subslover | investorshub | 04/19/2023 10:02:44 PM |
This thing warming up | Jess070283 | investorshub | 04/19/2023 8:38:55 PM |
MomentumIts now last up | TheFinalCD | investorshub | 04/19/2023 4:55:54 AM |
What are we thinking here | heyitsmeagain | investorshub | 04/18/2023 9:48:51 PM |
Long and strong lets hope im right | Zardiw | investorshub | 04/18/2023 9:44:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pion...
Data demonstrates that Company's Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor response...